Solve Therapeutics

formerly Solve Tx

Targeting cancer with best-in-class ADCs

Belmont, United States · Founded 2021 · $321.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$321.0M
Last Round
$120.0M Series BNov 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Solve Therapeutics develops antibody-drug conjugates for oncology that pair tumor-targeting antibodies with payload-delivery technology. Its proprietary CloakLink hydrophilic linker system is designed to improve selectivity and optimize payload delivery. The company applies precision engineering across ADC components to advance cancer therapies for patients with solid tumors.

Summary

Solve Therapeutics is a Life Sciences company based in Belmont, United States, founded in 2021. It has raised $321.0M in total across 3 rounds, most recently a $120.0M Series B round in Nov 2025. Investors include Yosemite, OrbiMed and Ally Bridge Group.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BNov 2025
$120.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Solve Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/solve-therapeutics"><img src="https://indexed.vc/api/badge/company/solve-therapeutics" alt="Solve Therapeutics on Indexed.vc" width="260" height="76" /></a>